--- schema_version: "secwatch.filing_event.v1" accession: "0001104659-23-001886" form_type: "8-K" ticker: "NWBO" cik: "0001072379" company_name: "NORTHWEST BIOTHERAPEUTICS INC" filed_at: "2023-01-06T23:59:59+00:00" generated_at: "2026-06-20T18:33:59.011470+00:00" event_type: "other_material" sentiment: "neutral" materiality_score: 0.6 calibrated_materiality_score: 0.15 confidence: "high" source: SEC EDGAR --- # Northwest Biotherapeutics shareholders approve all six proposals at 2022 annual meeting ## Summary - Re-elected directors Linda F. Powers and Navid Malik with 97.2% and 97.5% of votes cast respectively. - Ratified Cherry Bekaert LLP as auditor for FY2022 with 98.8% of votes cast. - Approved increase of authorized common shares from 1.2B to 1.7B with 95% of votes cast (73.8% of outstanding common). - Approved advisory say-on-pay for 2021 executive compensation with 91.9% support. - Ratified 2020 option awards to executives and independent directors with over 90% approval each. ## SEC filing metadata - accession: 0001104659-23-001886 - form_type: 8-K - ticker: NWBO - cik: 0001072379 - company_name: NORTHWEST BIOTHERAPEUTICS INC - filed_at: 2023-01-06T23:59:59+00:00 - event_type: other_material - sentiment: neutral - materiality_score: 0.6 - calibrated_materiality_score: 0.15 - confidence: high - sec_items: 5.07 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1072379/000110465923001886/0001104659-23-001886-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1072379/000110465923001886/tm231540d1_8k.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001104659-23-001886 - JSON: https://secwatch.observer/filing/0001104659-23-001886.json - Plain text: https://secwatch.observer/filing/0001104659-23-001886.txt ## Key facts - Shareholder Votes NORTHWEST BIOTHERAPEUTICS INC shareholders approved Approval of previously reported 2020 option awards to the Company's independent directors at the 2022-12-30 meeting. - Proposal: equity plan - Outcome: passed - Meeting: 2022-12-30 source text: The votes for approval were as follows: For Against Abstained Broker Non-Votes Approval of 2020 Option Awards to the Company's Independent Directors 619,934,754 (90.4%) 65,686,803 (9.6%) 8,392,803 (N/A) 147,209,551 (N/A) evidence_url: https://www.sec.gov/Archives/edgar/data/1072379/000110465923001886/0001104659-23-001886-index.htm - Shareholder Votes NORTHWEST BIOTHERAPEUTICS INC shareholders approved Election of Directors at the 2022-12-30 meeting. - Proposal: director election - Outcome: passed - Meeting: 2022-12-30 source text: The votes for Ms. Powers and Dr. Malik were as follows: For Withheld Broker Non-Votes Ms. Linda F. Powers 674,562,624 (97.2%) 19,451,736 (2.8%) 147,209,551 (N/A) Dr. Navid Malik 676,764,972 (97.5%) 17,249,388 (2.5%) 147,209,551 (N/A) evidence_url: https://www.sec.gov/Archives/edgar/data/1072379/000110465923001886/0001104659-23-001886-index.htm - Shareholder Votes NORTHWEST BIOTHERAPEUTICS INC shareholders approved Approval of amendment to Certificate of Incorporation to increase authorized shares of common stock from 1,200,000,000 to 1,700,000,000 at the 2022-12-30 meeting. - Proposal: charter amendment - Outcome: passed - Meeting: 2022-12-30 source text: The votes for approval by the common and preferred stockholders, voting together as a single class, as a percentage of votes cast, and as a percentage of the total outstanding shares of Common and Preferred Stock combined as of the record date, were as follows: For Against Abstained Broker Non-Votes Common Stock Increase Amendment 799,877,480 37,214,287 4,132,144 0 Percent of votes cast (95.1%) (4.4%) (0.5%) Percent of total Common & Preferred Stock (74.3%) (3.5%) (0.4%) evidence_url: https://www.sec.gov/Archives/edgar/data/1072379/000110465923001886/0001104659-23-001886-index.htm - Shareholder Votes NORTHWEST BIOTHERAPEUTICS INC shareholders approved Ratification of Appointment of Cherry Bekaert LLP as the independent registered public accounting firm at the 2022-12-30 meeting. - Proposal: auditor ratification - Outcome: passed - Meeting: 2022-12-30 source text: The votes for appointment of Cherry Bekaert were as follows: For Against Abstained Broker Non-Votes Ratification of Cherry Bekaert LLP 829,094,918 (98.8%) 9,951,520 (1.2%) 2,177,473 (N/A) 0 evidence_url: https://www.sec.gov/Archives/edgar/data/1072379/000110465923001886/0001104659-23-001886-index.htm - Shareholder Votes NORTHWEST BIOTHERAPEUTICS INC shareholders approved Ratification of the same option awards made in 2020 to the Company's named executive officers at the 2022-12-30 meeting. - Proposal: equity plan - Outcome: passed - Meeting: 2022-12-30 source text: The votes for ratification were as follows: For Against Abstained Broker Non-Votes Ratification of Named Executive Officer Option Awards 613,009,482 (90.0%) 68,146,624 (10.0%) 12,858,254 (N/A) 147,209,551 (N/A) evidence_url: https://www.sec.gov/Archives/edgar/data/1072379/000110465923001886/0001104659-23-001886-index.htm - Shareholder Votes NORTHWEST BIOTHERAPEUTICS INC shareholders approved Advisory vote on 2021 executive compensation at the 2022-12-30 meeting. - Proposal: say on pay - Outcome: passed - Meeting: 2022-12-30 source text: The votes for approval were as follows: For Against Abstained Broker Non-Votes Approval of 2021 Executive Compensation 625,747,069 (91.9%) 55,153,546 (8.1%) 13,113,745 (N/A) 147,209,551 (N/A) evidence_url: https://www.sec.gov/Archives/edgar/data/1072379/000110465923001886/0001104659-23-001886-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.